What is the CVR number of QuickTest-ToGo ApS?

QuickTest-ToGo ApS is registered with CVR / Virk under CVR 40223584.

What is the revenue of QuickTest-ToGo ApS?

QuickTest-ToGo ApS reported revenue of DKK -10K in 2024.

How many employees does QuickTest-ToGo ApS have?

QuickTest-ToGo ApS employs 1 people as of the latest annual report.

Who is the CEO of QuickTest-ToGo ApS?

Henk Akse is Management of QuickTest-ToGo ApS, in role since 2021.

Where is QuickTest-ToGo ApS headquartered?

QuickTest-ToGo ApS's registered address is Kranvejen 59.

QuickTest-ToGo ApS

APSActive

CVR 40223584Kranvejen 59Traditional, complementary and alternative medicine activities · NACE 8696Est. 20191 employees

Full Risika report

Revenue 2024

DKK -10K

-89% vs 2023

EBITDA margin

100.0%

+89% vs 2023

Equity ratio

-13825.8%

Financial strength

Net profit 2024

DKK -10K

+89% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -10K	-89%
EBITDA	DKK -10K	+89%
Net profit	DKK -10K	+89%
Total assets	DKK 163	+63%
Equity	DKK -23K	-83%
Employees	1	—

Item	2019	2020	2021	2022	2023	2024
Revenue	0	0	573	306	-92	-10
Staff expenses	-0	-0	-339	-349	-0	-0
EBITDA	0	0	234	-44	-92	-10
Depreciation & amort.	-0	-0	-0	-0	-0	-0
EBIT	0	0	234	-44	-92	-10
Net financials	0	0	-1	-1	-0	-0
Profit before tax	0	0	233	-45	-92	-10
Tax	-0	-0	52	2	-0	-0
Net profit	0	0	181	-47	-92	-10

Item	2021	2022	2023	2024
Total assets	317	124	0	0
Equity	181	79	-12	-23
Long-term debt	0	0	0	0
Short-term debt	137	45	12	23
Total debt	137	45	12	23

Name	Role	Member since	Age	Other directorships
HA Henk Akse Management	Management	2021	—	—
JS Jesper Sveegaard Holmgren Management	Management	2019	—	—

Shareholder	Type	Ownership	Votes	Since
Silent Holding ApS	Company	100.0%	100.0%	2023
D65 Holding	Individual	50.0%	50.0%	2021
Henk Akse	Individual	50.0%	50.0%	2021
Clément Egbert-Jan Hamer	Individual	15.0%	15.0%	2021

Person	Role here	Other companies
Henk Akse	Management	0 companies
Jesper Sveegaard Holmgren	Management	0 companies

QuickTest-ToGo ApS

APSActive

CVR 40223584Kranvejen 59Traditional, complementary and alternative medicine activities · NACE 8696Est. 20191 employees

Full Risika report

Revenue 2024

DKK -10K

-89% vs 2023

EBITDA margin

100.0%

+89% vs 2023

Equity ratio

-13825.8%

Financial strength

Net profit 2024

DKK -10K

+89% vs 2023

EBITDA — year on yearDKK millions

Key figuresAnnual report 2024

Revenue	DKK -10K	-89%
EBITDA	DKK -10K	+89%
Net profit	DKK -10K	+89%
Total assets	DKK 163	+63%
Equity	DKK -23K	-83%
Employees	1	—